These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 313478)

  • 1. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [H-MTX-CF treatment and osteogenic sarcoma (author's transl)].
    Goto M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):235. PubMed ID: 6976923
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
    Sauer H; Wilmanns W
    Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of overall toxicity of high-dosage methotrexate regimens.
    Perez C; Sutow WW; Wang YM; Herson J
    Med Pediatr Oncol; 1979; 6(3):219-28. PubMed ID: 314042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate with a safe rescue program.
    Decker DA; Edmonson JH; Gilchrist GS; Kovach JS; Offord JR; Taylor WF
    Oncology; 1981; 38(5):262-4. PubMed ID: 6973732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum methotrexate determination by microbiological assay in patients receiving high-dosage methotrexate (author's transl)].
    Krisch K; Kotz D; Mehta BM
    Wien Klin Wochenschr; 1977 Jul; 89(14):479-81. PubMed ID: 268729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
    Cohen HJ; Jaffe N
    Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
    Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
    N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
    Breithaupt H; Küenzlen E
    Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)].
    Göbel U; Jürgens H; von Voss H; Wahn V; Rosen G
    Klin Padiatr; 1981 Mar; 193(2):94-8. PubMed ID: 6971958
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate clearance and clinical toxicity in osteosarcoma following high-dose methotrexate therapy.
    Iqbal MP; Khursheed M; Mahboobali N
    J Pak Med Assoc; 1989 Feb; 39(2):38-42. PubMed ID: 2499702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-pharmacological studies on the course of high-dose methotrexate therapy in childhood. A retrospective comparison of centers].
    Winograd B; Windorfer A; Wahlen W; Sitzman FC; Müller J; Wündisch G
    Dtsch Med Wochenschr; 1984 Jan; 109(4):127-32. PubMed ID: 6363035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
    Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
    Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma phenylalanine: tyrosine ratios during high-dose methotrexate-citrovorum "rescue".
    Hilton MA; Patel CC; Bertolone SJ; Kmetz DR; Clark LW
    Med Pediatr Oncol; 1982; 10(4):389-95. PubMed ID: 6981054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.